1. Home
  2. BEKE vs ILMN Comparison

BEKE vs ILMN Comparison

Compare BEKE & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BEKE

KE Holdings Inc (each representing three)

HOLD

Current Price

$15.94

Market Cap

18.8B

Sector

Finance

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$135.44

Market Cap

18.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEKE
ILMN
Founded
2001
1998
Country
China
United States
Employees
N/A
N/A
Industry
Real Estate
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.8B
18.9B
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
BEKE
ILMN
Price
$15.94
$135.44
Analyst Decision
Strong Buy
Hold
Analyst Count
5
16
Target Price
$24.36
$117.31
AVG Volume (30 Days)
4.2M
1.8M
Earning Date
11-10-2025
02-05-2026
Dividend Yield
2.23%
N/A
EPS Growth
N/A
N/A
EPS
0.42
4.46
Revenue
$14,540,474,652.00
$4,288,000,000.00
Revenue This Year
$7.14
N/A
Revenue Next Year
$4.90
$2.24
P/E Ratio
$38.67
$30.85
Revenue Growth
25.42
N/A
52 Week Low
$15.39
$68.70
52 Week High
$25.17
$153.06

Technical Indicators

Market Signals
Indicator
BEKE
ILMN
Relative Strength Index (RSI) 38.69 62.81
Support Level $15.94 $129.29
Resistance Level $16.28 $138.80
Average True Range (ATR) 0.31 3.99
MACD -0.09 -0.35
Stochastic Oscillator 5.99 77.29

Price Performance

Historical Comparison
BEKE
ILMN

About BEKE KE Holdings Inc (each representing three)

KE Holdings, or Beike, is a large residential real estate sales and rental brokerage company in China. Founded in 2001, the company operates through self-owned Lianjia stores in Beijing and Shanghai and connected third-party agencies, including franchise brand Deyou in other cities, with commissions charged on existing-home and new-home transactions. Leveraging an online-offline hybrid model, Beike also attract clients through its namesake online marketplace. The company tapped into home renovation services by acquiring Shengdu Home Decoration in 2022. As of the end of 2024, Beike's co-founders collectively control the company, while Tencent and its affiliates share 8% of voting power.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: